We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

BECKMAN COULTER, INC.

Beckman Coulter develops, manufactures and markets laboratory systems, reagents, centrifugation, lab automation, elec... read more Featured Products: More products

Download Mobile App





State-of-the-Art Automated Laboratory Systems Highlighted at the 2015 AACC Annual Meeting

By LabMedica International staff writers
Posted on 28 Jul 2015
Top-of-the-line automated diagnostic systems are highlighted in Booth 2409 at the 2015 AACC Annual Meeting & Clinical Lab Expo (Atlanta, GA, USA).

Beckman Coulter Diagnostics (Brea, CA, USA) is displaying its state-of-the-art laboratory instruments at this year's meeting. More...
Particular emphasis is being placed on the Power Express automation system for general clinical chemistry and the MicroScan WalkAway system for the microbiology lab.

Power Express is a connected clinical automation solution that consolidates all core disciplines—chemistry, immunochemistry, hematology, and coagulation—into a single automated line. Power Express performs multiple functions including sample login, centrifugation, decapping, aliquotting, presentation of samples for connected instruments, recapping, storing in ambient or refrigerated storage modules, and sorting to outlets. Intelligent sample management reduces variability and increases predictability because dynamic sample routing is based on test ordered and analyzers availability. Samples can crisscross and loop-back on track to analyzers, and smart carrier management ensures that high-throughput analyzers are optimized. Barcode sample reading at each sample aspiration maintains accuracy with positive patient identification.

The WalkAway plus microbiology system is the fourth generation of proven WalkAway technology and reliability. This platform delivers gold-standard accuracy for microorganism identification and susceptibility testing. It enables simultaneous processing of conventional, rapid, and specialty panels on a single, automated platform and delivers accurate resistance detection for emerging pathogens, including VISA, VRSA, and MRSA. The WalkAway plus System includes LabPro Information Management software designed to simplify workflow and minimize technologist interaction while accommodating differing regional and institutional environments through extensive customization features.

Visitors to the Beckman Coulter Diagnostics booth will be shown how the company is helping laboratories balance better patient care and efficiency to achieve goals such as standardized processes to achieve increased capacity while minimizing errors and reducing turnaround time to improve physician confidence.

“The American Association of Clinical Chemistry Annual Meeting allows us the opportunity to share with the diverse diagnostics laboratory industry how we partner to move healthcare forward,” said Arnd Kaldowski, president of Beckman Coulter Diagnostics. “This year, we are particularly eager to share our newest product offerings and demonstrate to laboratories in a unique, interactive way, how with personalized, expert attention, clinical data management tools and the Danaher Business System, laboratories can to drive continuous improvement and sustainment in today’s healthcare landscape.”

Related Links:

2015 AACC Annual Meeting & Clinical Lab Expo
Beckman Coulter Diagnostics 



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Platelet Function Analyzer
PL-12
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Electrolyte Analyzer
BKE-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Shutterstock

Blood Test Could Guide Drug Selection to Prevent Repeat Heart Attacks and Strokes

Secondary prevention after myocardial infarction or stroke relies on antiplatelet therapy, yet responses vary widely and both recurrent thrombosis and bleeding remain persistent risks. In the United Kingdom,... Read more

Molecular Diagnostics

view channel
Image: Signatera uses ctDNA analysis to identify residual tumor-derived genetic material after definitive treatment (image credit: Adobe Stock)

Blood-Based MRD Test Predicts Recurrence Risk After Lung Cancer Surgery

Assessing recurrence risk after surgery for early-stage non-small cell lung cancer remains challenging, complicating adjuvant therapy and surveillance decisions. Blood-based molecular residual disease... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Type 1 diabetes affects more than 9 million people worldwide and can begin years before symptoms appear, making early identification of at-risk children difficult (Image Credit: iStock)

Early-Life Gut Microbiome Changes May Help Assess Type 1 Diabetes Risk

Type 1 diabetes (T1D) affects more than 9 million people worldwide, including 1.8 million children and adolescents, and often begins years before symptoms appear. Early identification of children who are... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Central to the collaboration is the Enhanced Liver Fibrosis (ELF) test, a noninvasive blood test authorized in the U.S. to assess disease progression risk in patients with advanced fibrosis due to MASH and support patient management decisions. (Photo courtesy of Siemens Healthineers)

Siemens Healthineers and Novo Collaborate to Expand Access to Noninvasive Liver Testing

Metabolic dysfunction‑associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction‑associated steatohepatitis (MASH), affect millions and are linked to obesity, type 2 diabetes,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.